Navigation Links
Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP
Date:2/23/2009

apital necessary to fund its research and development activities; Vanda's failure to identify or obtain rights to new product candidates; Vanda's failure to develop or obtain sales, marketing and distribution resources and expertise or to otherwise manage its growth; a loss of any of Vanda's key scientists or management personnel; losses incurred from product liability claims made against Vanda; a loss of rights to develop and commercialize Vanda's products under its license and sublicense agreements and other factors that are described in the "Risk Factors" section (Part II, Item 1A) of Vanda's quarterly report on Form 10-Q for the quarter ended September 30, 2008 (File No. 000-51863). In addition to the risks described above and in Part II, Item 1A of Vanda's quarterly report on Form 10-Q, other unknown or unpredictable factors also could affect Vanda's results. There can be no assurance that the actual results or developments anticipated by Vanda will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Vanda. Therefore, no assurance can be given that the outcomes stated in such forward-looking statements and estimates will be achieved.

All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this release is provided only as of the date of this release, and Vanda undertakes no obligation, and specifically declines any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

IMPORTANT INFORMATION/SOLICITATION PARTICIPANTS LEGEND

Vanda Pharmaceuticals and its d
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
2. Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
3. Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
4. Vanda Pharmaceuticals Announces that it No Longer Intends to Offer Convertible Senior Notes
5. Vanda Pharmaceuticals VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties
6. Vanda Pharmaceuticals to Announce Third Quarter 2007 Financial Results on November 8, 2007
7. Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
8. Vanda Pharmaceuticals to Present at Natixis Bleichroeders Hidden Gems Conference
9. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
10. Nostrum Pharmaceuticals Obtains Worldwide Licensing Rights From IMTECH for Clinical Development of the Small Molecule Caerulomycin and Its Proprietary Derivatives for Their Novel Indication of Immunosuppression
11. Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Reproductive Science Center (RSC) of New ... Luzzo, Lead Physician at RSC Rhode Island, received the ... in fertility care and community outreach issued by Providence ... PBN Awards ceremony held July 24th at Salve Regina ... highly regarded, emerging leaders in their field were recognized ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Merrill ... of technology-enabled services for the financial, legal, healthcare ... virtual data room business, Merrill DataSite, has been ... presented by GrowthBusiness at the M&A Awards 2014 ... the achievements of entrepreneurs, management teams, advisors and ...
(Date:7/25/2014)... 2014 A new study of participants in ... are published today in Cancer , found evidence that ... who had an abnormal finding on a lung cancer screening ... life than did those who were screened and found to ... to the researchers. “We expected that participants with an abnormal ...
(Date:7/25/2014)... AZ (PRWEB) July 25, 2014 Hastings ... offering discount attorney’s fees with regard to personal ... Hastings provide a wide range of legal services for ... the negligence of another individual or corporation. Free initial ... determining the validity of a potential personal injury ...
(Date:7/25/2014)... Treatment for lymphoma may lower men,s fertility, new research ... are cancers of the body,s white blood cells, often ... years. For men, treatment for these cancers can harm ... fertility within two years of treatment, the researchers cautioned ... this significant side effect before treatment begins. "While ...
Breaking Medicine News(10 mins):Health News:Dr. Kerri Luzzo of the Reproductive Science Center of Providence Receives “40 Under Forty Award" for Outstanding Professional Accomplishments and Community Outreach 2Health News:Merrill DataSite Recognized as “Technology Provider of the Year” by GrowthBusiness at the M&A Awards 2014 Event 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 4Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 5Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3Health News:Lymphoma Treatment May Harm, Halt Men's Sperm Production 2
... man, who tested negative for the human form of the ... Diseases, in Bucharest// , after he exhibited flu like symptoms. ... H5N1 had infected the birds in the area. ... Bucharest national laboratory. The Ministry of Health has designated the ...
... rising obesity rates by 2010 will fall flat on its face, ... to a recent study// . Though local level work is going ... about the thrust given to this area. The public Health Minister, ... lots left to be done. Obesity has sent the NHS expenditure ...
... and Research Institutes, Inc (NDRI) in New York ... explored the role// of social supports, spirituality, religiousness, ... of recovery from addiction. The study reveals markedly ... as a decrease in stress when people were ...
... A 91-year-old woman in British Columbia died a lonely death after ... sons, is hopeful that his mom’s death// will bring about some ... ,The hospital separated Fanny Albo from her ailing husband who ... in Trail. Fanny Albo and her husband had been together for ...
... to a new Japanese study appearing in the current ... green tea daily may help reduce risk of dementia,.// ... related with the risk of having cognitive impairment in ... , Dr. Shinichi Kuriyama of Tohoku University Graduate ...
... Germany has reported that regular peelings and scrubbing with a ... the skin is stretched during pregnancy. // ,Peelings and ... magazine said. The same is true of massages. ... use of certain substances can help. ...
Cached Medicine News:Health News:Drug Addiction Recovery Buffered by Spirituality 2
(Date:7/25/2014)... July 25, 2014 Research and Markets ... Ophthalmic Diagnostic Devices Market 2014-2018" report to their ... About Ophthalmic Diagnostic Device An ... identify a defect or deficiency in the human visual ... disorders such as presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, ...
(Date:7/25/2014)...  Semler Scientific, Inc. (Nasdaq: SMLR ... that develops patented products that assist healthcare providers ... reported financial results for the second quarter and ... "The second quarter of 2014 continued to ... , M.D., chief executive officer of Semler.  "We ...
(Date:7/25/2014)... 25, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... update and report second quarter 2014 financial results before ... 1, 2014. That same day, Arena will host a ... (5:30 a.m. Pacific Time). The conference ... callers and 914.495.8552 for international callers. Please specify to ...
Breaking Medicine Technology:Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2Semler Reports Second Quarter 2014 Financial Results 2Semler Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3
... 2012    Octapharma USA has submitted its Biological License ... Food and Drug Administration (FDA) with the goal of ... 2012. The FDA will evaluate the octaplasLG® ... patients who require replacement of multiple plasma coagulation factors. The ...
... 27, 2012  Ventana Medical Systems, Inc. (Ventana), a member of ... Food and Drug Administration (FDA) for the VENTANA Companion ... VENTANA iScan Coreo Au scanner running ... offering an FDA cleared Ki-67 image analysis algorithm for ...
Cached Medicine Technology:Octapharma USA Submits BLA for octaplasLG®, a Therapy Targeting Adverse Transfusion Events 2Octapharma USA Submits BLA for octaplasLG®, a Therapy Targeting Adverse Transfusion Events 3Ventana Receives FDA Clearance for Ki-67 (30-9) Image Analysis and Digital Read Applications 2
Accommodates either eye. Slotted, malleable aluminum surface. Correct size holes produce ideal pin hole effect. Packaged 50 per box....
Blue plastic shield for reduced glare. Packaged 12 per box....
Non-reflective black anodized aluminum. Selection of five pin hole sizes (0.8 mm to 1.5 mm). Overall length: 4.0 inches....
4 mm x 4 mm downward biting jaws, curved right, length of shaft 115 mm, overall length 9.3 inches....
Medicine Products: